A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection

INTRODUCTION: More than a million people acquire HIV infection annually. Pre-exposure prophylaxis (PrEP) using antiretrovirals is currently being investigated for HIV prevention. Oral and topical formulations of tenofovir have undergone pre-clinical and clinical testing to assess acceptability, safe...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gengiah, Tanuja N, Pharm, MClin, Baxter, Cheryl, Mansoor, Leila E, Kharsany, Ayesha BM, Karim, Salim S Abdool
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3460694/
https://ncbi.nlm.nih.gov/pubmed/22394224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2012.667072
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky